Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chew

Showing results (461-470 of 487) with videos related to

Pageof 49
Sort By:
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 26, 2020
Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysisPaul Jie Wen Tern, Aaron Kwun Hang Ho, Rehena Sultana, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
The Medical Journal of Australia|March 26, 2019
Evaluating recruitment strategies for AUSPICE, a large Australian community-based randomised controlled trialRoseanne Peel, Shu Ren, Alexis Hure, et al.
European Heart Journal|October 29, 2024
Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survivalJason E Bloom, Sara Vogrin, Christopher M Reid, et al.
American Heart Journal|June 23, 2007
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR studyDeepak L Bhatt, Derek P Chew, Cindy Grines, et al.
The New England Journal of Medicine|November 17, 2009
Platelet inhibition with cangrelor in patients undergoing PCIRobert A Harrington, Gregg W Stone, Steven McNulty, et al.
The Medical Journal of Australia|August 6, 2013
Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS studyDerek P Chew, John French, Tom G Briffa, et al.
Journal of the American College of Cardiology|August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial InfarctionSunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
BMJ Open|January 29, 2018
TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocolClara K Chow, Aravinda Thiagalingam, Karla Santo, et al.
Pageof 49

Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 26, 2020
Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysisPaul Jie Wen Tern, Aaron Kwun Hang Ho, Rehena Sultana, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
The Medical Journal of Australia|March 26, 2019
Evaluating recruitment strategies for AUSPICE, a large Australian community-based randomised controlled trialRoseanne Peel, Shu Ren, Alexis Hure, et al.
European Heart Journal|October 29, 2024
Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survivalJason E Bloom, Sara Vogrin, Christopher M Reid, et al.
American Heart Journal|June 23, 2007
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR studyDeepak L Bhatt, Derek P Chew, Cindy Grines, et al.
The New England Journal of Medicine|November 17, 2009
Platelet inhibition with cangrelor in patients undergoing PCIRobert A Harrington, Gregg W Stone, Steven McNulty, et al.
The Medical Journal of Australia|August 6, 2013
Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS studyDerek P Chew, John French, Tom G Briffa, et al.
Journal of the American College of Cardiology|August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial InfarctionSunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
BMJ Open|January 29, 2018
TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocolClara K Chow, Aravinda Thiagalingam, Karla Santo, et al.
Pageof 49